Leprosy and AIDS: Two of increasing inflammatory reactions at the start of highly active antiretroviral therapy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 5, 2004, Pages 408-411

  Pignataro, P ^a   Da Silva Rocha, A ^a   Nery, J A C ^a   Miranda, A ^a   Sales, A M ^a   Ferrreira, H ^a   Valentim, V ^a   Suffys, P N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LEPROSTATIC AGENT; NELFINAVIR; SULFONE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY INFILTRATE; LEPROMIN TEST; LEPROSY; MALE; MEDICAL EXAMINATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM LEPRAE; NUCLEIC ACID ANALYSIS; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; SKIN ULCER; TREATMENT OUTCOME; AIDS RELATED COMPLEX; DELAYED HYPERSENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGY; MIDDLE AGED;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; INFLAMMATION; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE;

EID: 3042783337     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1131-7     Document Type: Article

References (25)

1. Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP (2002) Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease. AIDS Res Hum Retroviruses 18:95-102
2. Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM (1999) Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 103:1391-1398
3. DeSimone JA, Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133:447-454
4. Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM (2000) Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 130:49-56
5. Hassel M, French MA (2001) Mycobacterium avium infection and immune restoration disease after highly antiretroviral therapy in patient with HIV and normal CD4 counts. Eur J Clin Microbiol Infect Dis 20:889-891
6. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177-184
7. Zamir E, Hudson H, Ober RR, Kumar SK, Wang RC, Read RW, Rao NA (2002) Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? Ophthalmology 109:2144-2148
8. Bottieau E, Noe A, Florence E, Ostyn B, Colebunders R (2002) Development of multiple abscesses in an HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy. Acta Clin Belg 57:219-222
9. Bartralot R, Pujol RM, Garcia-Patos V, Sitjas D, Martin-Casabona N, Coll P, Alomar A, Castells A (2000) Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol 27:124-129
10. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T (1993) Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175-178
11. Santos AR, Balassiano V, Oliveira ML, Pereira MA, Santos PB, Degrave WM, Suffys PN (2001) Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy. Mem Inst Oswaldo Cruz 96:1129-1133
12. Devallois A, Picardeau M, Goh KS, Sola C, Vincent V, Rastogi N (1996) Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare. Clin Microbiol 34:2756-2759
13. da Silva Rocha A, Werneck Barreto AM, Dias Campos CE, Villas-Boas da Silva M, Fonseca L, Saad MH, Degrave WM, Suffys PN (2002) Novel allelic variants of Mycobacteria isolated in Brazil as determined by PCR-restriction enzyme analysis of hsp65. J Clin Microbiol 40:4191-4196
14. Freerksen E, Alvarenga AE, Leguizamon O, de Morra MV, von Ballestrem W, Reyes LA (1991) Short-term chemotherapy of leprosy using the combination rifampicin+cotrimoxazole +isoniazid. Med Klin 86:441-448
15. Leiber DL, Verhagen AR (1973) Assessment of the bacteriological effect of combined treatment with rifadin, sulfamethoxypyrazine, and isoniazide in lepromatous leprosy. Z Tropenmed Parasitol 24:32-35
16. Inderlied CB, Salfinger M (1999) Antimycobacterial agents and susceptibility tests. In: Murray PM, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington, DC, pp 1601-1623
17. Sharma RK, Katoch K, Sharma VD, Shivannavar CT, Natarajan M, Katoch VM (1995) Isolation and characterization of cultivable mycobacteria from leprosy skin. Indian J Lepr 67:321-328
18. del Giudice P, Durant J, Counillon E, Mondain V, Bernard E, Roger PM, Dellamonica P (1999) Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol 135:1129-1130
19. de Magalhaes VD, de Melo Azevedo Fda P, Pasternak J, Valle Martino MD (2002) Reliability of hsp65-RFLP analysis for identification of Mycobacterium species in cultured strains and clinical specimens. J Microbiol Methods 49:295-300
20. Converse PJ, Bjune G (1986) Natural killer (NK) cell activity and reversal reaction in leprosy. Int J Lepr Other Mycobact Dis 54:503-509
21. Ahmed AA, Nordlind K, Schultzberg M, Liden S (1994) Interleukin-1 alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm Venereol 74:435-440
22. Riedel DD, Kaufmann SH (2000) Differential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages. Microbes Infect 2:463-471
23. Beltan E, Horgen L, Rastogi N (2000) Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathog 28:313-318
24. Ghassemi M, Asadi FK, Andersen BR, Novak RM (2000) Mycobacterium avium induces HIV upregulation through mechanisms independent of cytokine induction. AIDS Res Hum Retroviruses 16:435-440
25. Manning AM, Rao A (1999) Agents targeting transcription factors. In: Gallin JI, Snyderman R (eds) Inflammation: basic principles and correlates. Lippincott Williams & Wilkins, Philadelphia, pp 1159-1176